rs863224453
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_002354.3(EPCAM):c.859-1G>A variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_002354.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Lynch syndrome 8Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- congenital diarrhea 5 with tufting enteropathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, G2P, Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EPCAM | ENST00000263735.9 | c.859-1G>A | splice_acceptor_variant, intron_variant | Intron 7 of 8 | 1 | NM_002354.3 | ENSP00000263735.4 | |||
| EPCAM | ENST00000405271.5 | c.943-1G>A | splice_acceptor_variant, intron_variant | Intron 8 of 9 | 5 | ENSP00000385476.1 | ||||
| EPCAM | ENST00000456133.5 | n.943-1G>A | splice_acceptor_variant, intron_variant | Intron 8 of 10 | 5 | ENSP00000410675.1 | ||||
| EPCAM | ENST00000490733.1 | n.708-1G>A | splice_acceptor_variant, intron_variant | Intron 5 of 5 | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This sequence change affects an acceptor splice site in intron 7 of the EPCAM gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in EPCAM are known to be pathogenic (PMID: 24142340, 28361844). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with EPCAM-related conditions. Deletions involving the 3’ region (minimally, exon 9) lead to transcriptional read-through from the EPCAM promoter into the adjacent MSH2 gene, resulting in hypermethylation of the MSH2 promoter and silencing of MSH2 expression, causing Lynch syndrome (PMID: 19098912, 19177550, 21309036). However, variants resulting in a loss-of-function of the EPCAM protein while leaving exon 9 intact are known to cause congenital tufting enteropathy (PMID: 24142340, 28361844). For these reasons, this variant has been classified as Likely Pathogenic for congenital tufting enteropathy. However, this variant is not likely to confer risk for Lynch syndrome. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at